Kanako Miyano, Miki Nonaka, Masahiro Sakamoto, Mika Murofushi, Yuki Yoshida, Kyoko Komura, Katsuya Ohbuchi, Yoshikazu Higami, Hideaki Fujii, Yasuhito Uezono. The Inhibition of TREK-1 K+ Channels via Multiple Compounds Contained in the Six Kamikihito Components, Potentially Stimulating Oxytocin Neuron Pathways. International Journal of Molecular Sciences. 2024. 25. 9. 4907-4907
Takashi Iwai, Rei Mishima, Shigeto Hirayama, Honoka Nakajima, Misa Oyama, Shun Watanabe, Hideaki Fujii, Mitsuo Tanabe. SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis. Journal of Clinical Medicine. 2024. 13. 2. 608-608
Fumika Karaki, Taro Takamori, Koumei Kawakami, Sae Sakurai, Kyoko Hidaka, Kei Ishii, Tomoya Oki, Noriko Sato, Nao Atsumi, Karin Ashizawa, et al. Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol. Molecules. 2023. 28. 19. 6925-6925
Yuki Moriya, Yoshiyuki Kasahara, Masafumi Shimada, Yasufumi Sakakibara, Hideaki Fujii, Hiroshi Nagase, Soichiro Ide, Kazutaka Ikeda, F. Scott Hall, George R. Uhl, et al. Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127. Journal of Pharmacological Sciences. 2023. 151. 3. 135-141
Takaaki Mizuguchi, Kanako Miyano, Risa Yamauchi, Yuki Yoshida, Hideki Takahashi, Ami Yamazaki, Haruka Ono, Miku Inagaki, Miki Nonaka, Yasuhito Uezono, et al. The first structure-activity relationship study of oxytocin as a positive allosteric modulator for the μ opioid receptor. Peptides. 2023. 159. 170901-170901
Fumika Karaki, Hideaki Fujii. Recent progress in the construction of sp3-rich compound libraries with natural product-like properties. Studies in Natural Products Chemistry. 2024. 81. 1-37
Hideaki Fujii. New Advances in the Medicinal Chemistry of Opioid Receptor Ligands. Current Topics in Medicinal Chemistry. 2020. 20. 31. 2821-2821